Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2017, Article ID 1023538, 4 pages
https://doi.org/10.1155/2017/1023538
Case Report

Subacute Disseminated Intravascular Coagulation in a Patient with Liver Metastases of a Renal Cell Carcinoma

Department of Internal Medicine, Zaans Medisch Centrum, Zaandam, Netherlands

Correspondence should be addressed to L. C. van der Wekken; ln.cmsnaaz@w.nekkew

Received 14 December 2016; Revised 22 March 2017; Accepted 28 March 2017; Published 5 April 2017

Academic Editor: Peter F. Lenehan

Copyright © 2017 L. C. van der Wekken and R. J. L. F. Loffeld. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013. View at Google Scholar
  2. A. J. Pantuck, A. Zisman, and A. S. Belldegrun, “The changing natural history of renal cell carcinoma,” The Journal of Urology, vol. 166, no. 5, pp. 1611–1623, 2001. View at Google Scholar
  3. M. Levi, C. H. Toh, J. Thachil, and H. G. Watson, “Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology,” British Journal of Haematology, vol. 145, no. 1, pp. 24–33, 2009. View at Google Scholar
  4. J. Thaler, I. Pabinger, W. R. Sperr, and C. Ay, “Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia,” Thrombosis Research, vol. 133, no. 3, pp. 303–305, 2014. View at Google Scholar
  5. M. Levi, “Disseminated intravascular coagulation in cancer patients,” Best Practice & Research Clinical Haematology, vol. 22, no. 1, pp. 129–136, 2009. View at Google Scholar
  6. T. Baglin, “Disseminated intravascular coagulation: diagnosis and treatment,” British Medical Journal, vol. 312, no. 7032, pp. 683–687, 1996. View at Google Scholar
  7. M. Levi, “Cancer-related coagulopathies,” Thrombosis Research, vol. 133, supplement 2, pp. S70–S75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Bick, “Disseminated intravascular coagulation and related syndromes: a clinical review,” Seminars in Thrombosis and Hemostasis, vol. 14, no. 04, pp. 299–338, 1988. View at Publisher · View at Google Scholar
  9. S. Sallah, J. Y. Wan, N. P. Nguyen, L. R. Hanrahan, and G. Sigounas, “Disseminated intravascular coagulation in solid tumors: clinical and pathologic study,” Thrombosis and Haemostasis, vol. 86, no. 3, pp. 828–833, 2001. View at Google Scholar · View at Scopus
  10. Y. Zhang, Y. Deng, T. Luther et al., “Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice,” Journal of Clinical Investigation, vol. 94, no. 3, pp. 1320–1327, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. B. C. Kuenen, M. Levi, J. C. M. Meijers et al., “Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 9, pp. 1500–1505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Gregory, J. H. Morrissey, and T. S. Edgington, “Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin,” Molecular and Cellular Biology, vol. 9, no. 6, pp. 2752–2755, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. M. B. Donati, “Cancer and thrombosis: from phlegmasia alba dolens to transgenic mice,” Thrombosis and Haemostasis, vol. 74, no. 1, pp. 278–281, 1995. View at Google Scholar · View at Scopus
  14. T. Pernerstorfer, U. Hollenstein, J.-B. Hansen et al., “Heparin blunts endotoxin-induced coagulation activation,” Circulation, vol. 100, no. 25, pp. 2485–2490, 1999. View at Publisher · View at Google Scholar · View at Scopus